Literature DB >> 30578588

Differential impact of age on survival in head and neck cancer according to classic Cox regression and decision tree analysis.

Ching-Chieh Yang1,2,3, Yu-Chieh Su4,5, Yu-Wei Lin1,2, Chung-I Huang6, Ching-Chih Lee7,8,9,10.   

Abstract

OBJECTIVES: To assess the impact of age on the survival of patients with head and neck squamous cell carcinoma (HNSCC) using different statistical methods.
DESIGN: A retrospective population-based study.
SETTING: Surveillance, Epidemiology, and End Results database. SUBJECTS AND METHODS: A total of 28 639 patients with newly diagnosed HNSCC were enrolled between 1 January 2007 and 31 December 2013. The effect of age on 5-year disease-specific survival was calculated using a Kaplan-Meier method and compared using log-rank tests. A Cox proportional hazards model was used for a multivariate analysis. A classification and regression tree (CART) analysis that partitioned patients with significantly different Kaplan-Meier curves was introduced to identify the important cancer-related parameters influencing survival.
RESULTS: Uni- and multivariate analyses indicated that patients who were older than 60 years had poorer 5-year disease-specific survival regardless of tumour subsite and tumor-node-metastasis (TNM) stage. However, the CART analysis determined that age played only a minor role in survival after comparing with other prognosticators. The relative importance of age using the Gini index was as follows: 3.21% for oral cancer, 8.32% for oropharyngeal cancer, 2.56% for hypopharyngeal cancer and 16.51% for laryngeal cancer.
CONCLUSIONS: Different to traditional statistical methods, the CART analysis which was used to identify homogeneous populations revealed that the impact of age varied for different patient groups according to the presence or absence of other prognosticators. This important information could help to guide our clinical decisions and future researches.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  age; classification and regression tree; head and neck squamous cell carcinoma; regression analysis; survival

Mesh:

Year:  2019        PMID: 30578588     DOI: 10.1111/coa.13274

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  5 in total

1.  Does age influence disease-specific survival in patients with squamous cell carcinomas of the head and neck?

Authors:  Joan Lop; Cristina Valero; Jacinto García; Miquel Quer; Ian Ganly; Jatin P Shah; Snehal G Patel; Xavier León
Journal:  J Surg Oncol       Date:  2020-03-09       Impact factor: 3.454

2.  Prognostic Significance of Peripheral T-Cell Subsets in Laryngeal Squamous Cell Carcinoma.

Authors:  Filippo Marchi; Francesco Missale; Fabiola Incandela; Marta Filauro; Francesco Mazzola; Francesco Mora; Alberto Paderno; Giampiero Parrinello; Cesare Piazza; Giorgio Peretti
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-08-28

3.  Radiotherapy-Induced Changes in the Systemic Immune and Inflammation Parameters of Head and Neck Cancer Patients.

Authors:  Katalin Balázs; Enikő Kis; Christophe Badie; Enikő Noémi Bogdándi; Serge Candéias; Lourdes Cruz Garcia; Iwona Dominczyk; Benjamin Frey; Udo Gaipl; Zsolt Jurányi; Zsuzsa S Kocsis; Eric Andreas Rutten; Géza Sáfrány; Piotr Widlak; Katalin Lumniczky
Journal:  Cancers (Basel)       Date:  2019-09-06       Impact factor: 6.639

4.  Proteomic analysis of hypopharyngeal and laryngeal squamous cell carcinoma sheds light on differences in survival.

Authors:  Jiajia Liu; Weiming Zhu; Zhexuan Li; Gengming Cai; Juncheng Wang; Qinglai Tang; Christopher A Maroun; Gangcai Zhu
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

5.  Predictors for distant metastasis in head and neck cancer, with emphasis on age.

Authors:  Martine F van der Kamp; Friso O W Muntinghe; René S Iepsma; Boudewijn E C Plaat; Bernard F A M van der Laan; Ayat Algassab; Roel J H M Steenbakkers; Max J H Witjes; Boukje A C van Dijk; Geertruida H de Bock; Gyorgy B Halmos
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-06-15       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.